BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 15974642)

  • 1. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
    Drugs Aging; 2005; 22(6):525-39. PubMed ID: 15974642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
    Clin Pharmacol Ther; 2002 Sep; 72(3):276-87. PubMed ID: 12235448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Khan IA; Shah A
    Clin Pharmacol Ther; 2005 May; 77(5):415-26. PubMed ID: 15900287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Carrier J; Khan IA; Edwards DJ; Shah A
    Clin Pharmacol Ther; 2004 Nov; 76(5):428-40. PubMed ID: 15536458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
    Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
    Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between herbal medicines and prescribed drugs: an updated systematic review.
    Izzo AA; Ernst E
    Drugs; 2009; 69(13):1777-98. PubMed ID: 19719333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
    Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
    Gurley BJ; Swain A; Hubbard MA; Williams DK; Barone G; Hartsfield F; Tong Y; Carrier DJ; Cheboyina S; Battu SK
    Mol Nutr Food Res; 2008 Jul; 52(7):755-63. PubMed ID: 18214849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical herbal interactions with conventional drugs: from molecules to maladies.
    Chen XW; Serag ES; Sneed KB; Liang J; Chew H; Pan SY; Zhou SF
    Curr Med Chem; 2011; 18(31):4836-50. PubMed ID: 21919844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.
    Gurley BJ; Swain A; Williams DK; Barone G; Battu SK
    Mol Nutr Food Res; 2008 Jul; 52(7):772-9. PubMed ID: 18214850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.
    Dresser GK; Schwarz UI; Wilkinson GR; Kim RB
    Clin Pharmacol Ther; 2003 Jan; 73(1):41-50. PubMed ID: 12545142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats.
    Zhang Y; Miao L; Lin L; Ren CY; Liu JX; Cui YM
    Phytomedicine; 2018 Jan; 38():125-134. PubMed ID: 29425645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
    Bell EC; Ravis WR; Lloyd KB; Stokes TJ
    Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
    Frye RF; Branch RA
    Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.
    Zou L; Harkey MR; Henderson GL
    Life Sci; 2002 Aug; 71(13):1579-89. PubMed ID: 12127912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.